KCM
HZNP

Kornitzer Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Kornitzer Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-24,700
Closed -$2.86M – 497
2023
Q3 		$2.86M Hold
24,700
– – 0.06% 281
2023
Q2 		$2.54M Hold
24,700
– – 0.05% 308
2023
Q1 		$2.7M Sell
24,700
-465
-2% -$51.4K 0.05% 294
2022
Q4 		$2.86M Sell
25,165
-227,621
-90% -$18.9M 0.06% 292
2022
Q3 		$15.6M Sell
252,786
-12,594
-5% -$880K 0.34% 79
2022
Q2 		$21.2M Hold
265,380
– – 0.42% 65
2022
Q1 		$27.9M Hold
265,380
– – 0.46% 57
2021
Q4 		$28.6M Sell
265,380
-75
-0% -$8.18K 0.43% 62
2021
Q3 		$29.1M Buy
265,455
+46,145
+21% +$4.79M 0.45% 59
2021
Q2 		$20.5M Sell
219,310
-80,965
-27% -$7.45M 0.31% 123
2021
Q1 		$27.6M Sell
300,275
-55
-0% -$4.64K 0.44% 68
2020
Q4 		$22M Buy
300,330
+280,330
+1,402% +$20.8M 0.37% 84
2020
Q3 		$1.55M Buy
+20,000
New +$1.38M 0.03% 353

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kornitzer Capital Management's HZNP Position: Q4 2023 in Review

Kornitzer Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 24,700 shares — an estimated $2.86M sold.

Kornitzer Capital Management first reported a position in HZNP in Q3 2020 and held it in 13 quarters. The position peaked at $29.1M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Kornitzer Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Kornitzer Capital Management sold 24,700 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.86M.
  • Kornitzer Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 13 quarters.
  • Kornitzer Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $29.1M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Kornitzer Capital Management's 13F filing for Q4 2023, filed 31 Jan 2024.